| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 01KC87F8FE |
| InChI Key | KRWMERLEINMZFT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H11N5O |
| Molecular Weight | 241.25 |
| AlogP | 1.51 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 89.71 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 18.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase CDK family
CMGC protein kinase CDC2 subfamily
|
- | 24000-24000 | - | - | - | |
|
Enzyme
|
- | 39-2600 | - | - | - | |
|
Other cytosolic protein
|
- | 24000-24000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Sezary Syndrome | 1 | D012751 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Mycosis Fungoides | 1 | D009182 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Lymphoma, T-Cell, Cutaneous | 1 | D016410 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL407874 |
| DrugBank | DB11919 |
| EPA CompTox | DTXSID20173700 |
| FDA SRS | 01KC87F8FE |
| PDB | OBG |
| PubChem | 4578 |
| SureChEMBL | SCHEMBL61740 |
| ZINC | ZINC000005425464 |